retinopathy of prematurityzone I and zone II posterior diseasezone I diseaseROPanti-VEGF agentslaser treatment
…demonstrated efficacy and short-term safety in the treatment of retinopathy of prematurity (ROP), establishing them as the preferred option for zone I and…